Read our monthly recap of some of the biggest FDA-related stories that have hit cardiology, including updates related to Cytokinetics, Dexcom and Abiomed. 

Seven members have been added to the Health Information Technology Advisory Committee (HITAC), a group tasked with improving the quality and access of health IT by the Government Accountability Office (GAO).

Out of 10 mock exams, the AI candidate passed two, achieving an overall accuracy of 79.5%, suggesting that the candidate is not quite “ready to graduate.” 

Healthcare stakeholders throughout U.S. medicine, including radiology leaders, aren’t waiting for the ink to dry before speaking their minds.

The news follows the departure of MetroHealth’s CEO, who was fired by the board of trustees after it was discovered he had been giving himself unauthorized bonuses totaling $1.9 million.

A molecular contrast agent previously cleared for use during surgery for ovarian cancer may now be used in similar fashion during lung operations.

A population-level study featuring multi-organ MRI has confirmed that problems in any of three major organs—the heart, brain or liver—tend to co-occur with unfavorable findings in either or both of the other two.

Mahadevappa Mahesh, PhD, professor of radiology and a medical physicist at the Johns Hopkins University School of Medicine, explains a new ACR effort to ensure that lower radiation dose X-ray images under Image Wisely and As Low as Reasonable Achievable (ALARA) meet diagnostic reading standards.